August 27, 2026
According to Payal Rabde, who specializes in biopharmaceuticals, biosimilars, and healthcare market intelligence, with 4+ years of experience in market research and industry analysis, the biosimilars market is set for strong long-term expansion, grow...
April 21, 2026
Projections indicate that, the global aflibercept biosimilars market will increase from USD 1.54 billion in 2024 to USD 3.7 billion by 2034, experiencing a CAGR of 9.14% over the next 10 years. The maturing ophthalmic biosimilar ecosystem is estimate...
August 10, 2026
According to Payal Rabde, who specializes in the development, manufacturing, and commercialization of biologic medicines, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities...